BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.470
-0.030 (-2.00%)
Aug 14, 2025, 11:47 AM - Market open
BioRestorative Therapies Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for BioRestorative Therapies.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for BioRestorative Therapies.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +1,124.49% | Aug 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +920.41% | Jun 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +920.41% | Aug 14, 2023 |
| Roth Capital | Roth Capital | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +920.41% | Dec 7, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +308.16% | Sep 28, 2022 |
Financial Forecast
Revenue This Year
1.27M
from 401.00K
Increased by 216.71%
Revenue Next Year
2.04M
from 1.27M
Increased by 60.63%
EPS This Year
-1.63
from -1.16
EPS Next Year
-1.08
from -1.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 2.6M | 97.4M | ||
| Avg | 1.3M | 2.0M | 48.9M | ||
| Low | 906,500 | 1.5M | 3.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 309.7% | 106.7% | 4,672.5% | ||
| Avg | 216.7% | 60.6% | 2,296.2% | ||
| Low | 126.1% | 15.7% | 50.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.51 | -0.86 | 3.28 | ||
| Avg | -1.63 | -1.08 | 1.23 | ||
| Low | -1.72 | -1.27 | -0.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.